Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nordea and Swedbank in connection with K2A’s establishment of its MTN programme
Mandate

Vinge advises Nordea and Swedbank in connection with K2A’s establishment of its MTN programme

May 21, 2021 Banking and Finance

Vinge has advised Nordea Bank Abp and Swedbank AB (publ) as lead arrangers and issuing agents in connection with the structuring, documenting and establishment of K2A Knaust & Andersson Fastigheter AB (publ) (”K2A”) unsecured medium term note programme (the “MTN Programme”). The MTN Programme is part of K2A’s debt financing and allows K2A to issue senior unsecured medium term notes in an aggregate amount of up to SEK 3,000,000,000 in SEK or EUR, with a minimum tenor of one year.

In contrast to customary MTN programmes, the MTN Programme was structured to be aligned with the terms and structure of high yield bonds issued on a standalone basis – making the MTN Programme one of the first of its kind in Sweden.

K2A has prepared a base prospectus which has been approved by, and registered with, the Swedish Financial Supervisory Authority.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Felix Möller.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025